recent articles
Artera: Novel risk stratification tool advances the frontier of precision oncology by providing access to insights informing critical on-the-ground treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of...
Dave Fornell | February 06, 2023 - There are now more than 520 marker-cleared artificial intelligence (AI) medical algorithms available in the United States, according to the U.S. Food and Drug Administration (FDA)...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing